Each issue of PaperMoney is approximately 500 fact filled pages.
Click here for Pulp & Paper Radio International
The Paperitalo Library
Free Downloads
My Profile
Management Side
Technical Side
Chesapeake Corporation Dedicates Pharmaceutical Paperboard Packaging Plant in China
Kunshan, China, 18 October 2007 -- /PRNewswire/ -- Chesapeake Corporation (NYSE:CSK), a leading international supplier of value-added specialty paperboard, plastic, and pharmaceutical packaging, today dedicated its new pharmaceutical paperboard packaging plant in Kunshan, China.

The new plant joins Chesapeake's global network of plants supplying some of the world's largest pharmaceutical companies. It offers design service and houses state-of-the-art equipment for digital plate making, digital label printing, high-gloss varnishing, foil stamping, and laminating. This new 36,000 square foot facility complements Chesapeake's existing plant in Kunshan, which manufactures plastic bottles for the pharmaceutical market, by adding the production of paper-based packaging for domestic and multinational customers.

"By combining paperboard carton, label and eventually leaflet production capacity with our existing plastic packaging capability, we will be able to offer one-stop service for primary and secondary pharmaceutical packaging," said Andrew J. Kohut, Chesapeake president and chief executive officer. "Coupled with our advanced security measures and anti-counterfeiting technology, our customers will benefit from the latest technology available in pharmaceutical packaging."

Headquartered in Richmond, Virginia, Chesapeake Corporation is one of Europe's premier suppliers of folding cartons, leaflets, and labels, as well as plastic packaging for niche markets. The company has 47 locations in Europe, North America, Africa, and Asia and employs approximately 5400 people worldwide.

Source: Chesapeake Corporation

Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: